ArticleInfectious agents and cancer2026
Combined C-terminal truncation and point mutations in HBx in genotype D1 HBV-associated hepatocellular carcinoma.
Article in Infectious agents and cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHepatitis B virus (HBV) infection remains a major global cause of hepatocellular carcinoma (HCC), with the X protein (HBx) playing a central role in viral replication and host-virus interactions. Genetic variability within HBx, particularly in genotype D1, may influence disease progression through structural and functional alterations.
methodsIn this study, the HBx region from an HBV-infected patient with HCC was analyzed using high-resolution melting (HRM) and direct sequencing. The obtained sequence was compared with a genotype D1 reference, followed by in silico structural interpretation.
resultsSequence analysis revealed a distinct mutational profile characterized by multiple amino acid substitutions within the transactivation domain, including H94R, S101S (synonymous), L116S, and V131T, along with a C-terminal truncation spanning amino acids 142-154 (C-terminal deletion/truncation). These alterations were located within or adjacent to functionally important regions, including domains implicated in transcriptional regulation, mitochondrial signaling, and protein-protein interactions. HRM analysis demonstrated a shift in melting temperature consistent with altered nucleotide composition. Structural interpretation suggested that the combined presence of point mutations and C-terminal truncation may contribute to localized conformational changes and altered interaction potential, although no definitive functional conclusions can be drawn.
conclusionThe identified HBx variant represents a complex mutational pattern involving both non-synonymous substitutions and a C-terminal truncation, which may reflect a multi-step process of structural and functional perturbations. This observation expands the current understanding of HBx variability in genotype D1 HBV and highlights the potential relevance of combined mutational profiles in the context of HBV-associated hepatocarcinogenesis. Further studies are required to clarify the biological significance of these findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.